Morgan Stanley
ACB

Morgan Stanley’s Aurora Cannabis ACB Stock Holding History

Morgan Stanley’s Portfolio ACB Stock Details ACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Sell
240,698
-18,357
-7% -$61.4K ﹤0.01% 5415
2026
Q1 		$847K Sell
259,055
-145,329
-36% -$549K ﹤0.01% 5233
2025
Q4 		$1.71M Buy
404,384
+96,338
+31% +$471K ﹤0.01% 4912
2025
Q3 		$1.84M Buy
308,046
+25,626
+9% +$125K ﹤0.01% 4843
2025
Q2 		$1.2M Sell
282,420
-508,203
-64% -$2.46M ﹤0.01% 5009
2025
Q1 		$3.47M Buy
790,623
+509,873
+182% +$2.41M ﹤0.01% 4218
2024
Q4 		$1.19M Buy
280,750
+85,930
+44% +$422K ﹤0.01% 5003
2024
Q3 		$1.15M Buy
194,820
+25,727
+15% +$152K ﹤0.01% 4975
2024
Q2 		$781K Buy
169,093
+42,026
+33% +$266K ﹤0.01% 5102
2024
Q1 		$558K Buy
127,067
+31,226
+33% +$121K ﹤0.01% 5267
2023
Q4 		$456K Sell
95,841
-18,606
-16% -$89.7K ﹤0.01% 5336
2023
Q3 		$670K Buy
114,447
+44,335
+63% +$258K ﹤0.01% 5018
2023
Q2 		$375K Buy
70,112
+8,828
+14% +$52K ﹤0.01% 5363
2023
Q1 		$427K Sell
61,284
-47,918
-44% -$419K ﹤0.01% 5344
2022
Q4 		$1.01M Sell
109,202
-65,006
-37% -$775K ﹤0.01% 4865
2022
Q3 		$2.13M Sell
174,208
-64,338
-27% -$945K ﹤0.01% 4382
2022
Q2 		$3.15M Buy
238,546
+87,041
+57% +$2.18M ﹤0.01% 4162
2022
Q1 		$6.06M Buy
151,505
+74,863
+98% +$3.17M ﹤0.01% 3470
2021
Q4 		$4.15M Sell
76,642
-56,854
-43% -$3.82M ﹤0.01% 3908
2021
Q3 		$9.24M Buy
133,496
+33,246
+33% +$2.36M ﹤0.01% 2988
2021
Q2 		$9.06M Sell
100,250
-23,173
-19% -$2.01M ﹤0.01% 3106
2021
Q1 		$11.5M Buy
123,423
+28,533
+30% +$3.19M ﹤0.01% 2503
2020
Q4 		$7.88M Sell
94,890
-17,490
-16% -$1.27M ﹤0.01% 2766
2020
Q3 		$5.22M Buy
112,380
+70,505
+168% +$6.7M ﹤0.01% 2674
2020
Q2 		$5.2M Buy
41,875
+14,063
+51% +$1.6M ﹤0.01% 2619
2020
Q1 		$3.02M Buy
27,812
+3,212
+13% +$574K ﹤0.01% 2958
2019
Q4 		$6.38M Sell
24,600
-31,906
-56% -$11.9M ﹤0.01% 2914
2019
Q3 		$29.8M Sell
56,506
-10,360
-15% -$7.67M 0.01% 1197
2019
Q2 		$62.7M Sell
66,866
-31,507
-32% -$31.7M 0.02% 744
2019
Q1 		$107M Buy
98,373
+23,139
+31% +$20.7M 0.03% 512
2018
Q4 		$44.8M Buy
+75,234
New +$55.5M 0.01% 870

Other funds holding ACB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Morgan Stanley's ACB Position: Q2 2026 in Review

Morgan Stanley reduced its Aurora Cannabis (ACB) stake by 7.1% in Q2 2026, selling an estimated $61.4K and leaving 240,698 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #5415.

Morgan Stanley first reported a position in ACB in Q4 2018 and has held it in 31 quarters since. The position peaked at $107M in Q1 2019. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

  • Morgan Stanley held 240,698 shares of Aurora Cannabis worth $672K as of Q2 2026.
  • Morgan Stanley sold 18,357 Aurora Cannabis shares in Q2 2026, an estimated $61.4K.
  • Aurora Cannabis made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5415 holding.
  • Morgan Stanley first reported a position in Aurora Cannabis in Q4 2018 and has held it in 31 quarters since.
  • Morgan Stanley's Aurora Cannabis position peaked at $107M in Q1 2019.
  • 149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.